PubRank

Annual review of pathology (Annu Rev Pathol)

Journal PubWeight™ 370.59‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Mammalian sirtuins: biological insights and disease relevance. 2010 8.55
2 The senescence-associated secretory phenotype: the dark side of tumor suppression. 2010 7.58
3 Molecular genetics of colorectal cancer. 2011 7.24
4 Pancreatic cancer. 2008 6.96
5 Tumor stroma and regulation of cancer development. 2006 6.66
6 The pathology of influenza virus infections. 2008 5.37
7 Pathogenesis of liver fibrosis. 2011 5.27
8 Ovarian cancer. 2009 4.92
9 PTEN and the PI3-kinase pathway in cancer. 2009 4.83
10 Inflammation and atherosclerosis. 2006 4.47
11 MicroRNAs in cancer. 2009 4.47
12 Molecular pathology of malignant gliomas. 2006 4.24
13 Endoplasmic reticulum stress in disease pathogenesis. 2008 4.10
14 Immunobiology and pathogenesis of viral hepatitis. 2006 3.84
15 Mesenchymal stem cells: mechanisms of inflammation. 2011 3.65
16 Alternative macrophage activation and metabolism. 2011 3.59
17 Autophagy: basic principles and relevance to disease. 2008 3.52
18 MicroRNAs in cancer. 2013 3.50
19 NOD-like receptors: role in innate immunity and inflammatory disease. 2009 3.39
20 Nonalcoholic fatty liver disease: pathology and pathogenesis. 2010 3.36
21 The origins of medulloblastoma subtypes. 2008 3.36
22 The aging brain. 2008 3.28
23 Notch signaling in leukemia. 2008 3.21
24 The acute respiratory distress syndrome: pathogenesis and treatment. 2011 3.08
25 Mitochondrial energetics and therapeutics. 2010 3.07
26 The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. 2006 3.07
27 Molecular mechanisms of prion pathogenesis. 2008 3.05
28 Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. 2006 3.01
29 The inflammatory response to cell death. 2008 2.85
30 Spectrum of Epstein-Barr virus-associated diseases. 2006 2.79
31 VEGF-A and the induction of pathological angiogenesis. 2007 2.74
32 The cell biology of phagocytosis. 2011 2.71
33 Mechanisms of leukocyte transendothelial migration. 2011 2.70
34 Anti-inflammatory and proresolving lipid mediators. 2008 2.68
35 Pathogenesis of preeclampsia. 2010 2.66
36 KSHV infection and the pathogenesis of Kaposi's sarcoma. 2006 2.61
37 Von Hippel-Lindau disease. 2007 2.61
38 Cellular heterogeneity and molecular evolution in cancer. 2012 2.56
39 Pathogenesis of NUT midline carcinoma. 2011 2.55
40 The pathogenesis of sepsis. 2011 2.55
41 A glimpse of various pathogenetic mechanisms of diabetic nephropathy. 2011 2.51
42 Molecular biology and pathology of lymphangiogenesis. 2008 2.49
43 Chromosome translocation, B cell lymphoma, and activation-induced cytidine deaminase. 2012 2.45
44 The osteoclast: friend or foe? 2008 2.45
45 Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. 2013 2.44
46 Retinoids, retinoic acid receptors, and cancer. 2011 2.40
47 Parkinson's disease: genetics and pathogenesis. 2011 2.39
48 Molecular mechanisms of fragile X syndrome: a twenty-year perspective. 2011 2.39
49 Molecular pathobiology of gastrointestinal stromal sarcomas. 2008 2.38
50 Pathogenic mechanisms of HIV disease. 2011 2.36
Next 50